Logo image of IQV

IQVIA HOLDINGS INC (IQV) Stock Overview

USA - NYSE:IQV - US46266C1053 - Common Stock

220.52 USD
+0.61 (+0.28%)
Last: 10/24/2025, 7:35:34 PM
220.52 USD
0 (0%)
After Hours: 10/24/2025, 7:35:34 PM

IQV Key Statistics, Chart & Performance

Key Statistics
Market Cap37.49B
Revenue(TTM)15.70B
Net Income(TTM)1.24B
Shares170.00M
Float168.21M
52 Week High225.91
52 Week Low134.65
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)11.47
PE19.23
Fwd PE16.94
Earnings (Next)10-28 2025-10-28/bmo
IPO2013-05-09
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


IQV short term performance overview.The bars show the price performance of IQV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

IQV long term performance overview.The bars show the price performance of IQV in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20

The current stock price of IQV is 220.52 USD. In the past month the price increased by 22.81%. In the past year, price increased by 2.74%.

IQVIA HOLDINGS INC / IQV Daily stock chart

IQV Latest News, Press Relases and Analysis

IQV Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.56 216.18B
DHR DANAHER CORP 28.92 159.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 148.65 48.49B
A AGILENT TECHNOLOGIES INC 27.16 41.97B
MTD METTLER-TOLEDO INTERNATIONAL 35.07 29.55B
WST WEST PHARMACEUTICAL SERVICES 42.07 21.39B
WAT WATERS CORP 29.39 21.40B
MEDP MEDPACE HOLDINGS INC 42.32 17.00B
ILMN ILLUMINA INC 24.06 15.39B
TEM TEMPUS AI INC N/A 15.50B
ICLR ICON PLC 13.5 13.85B
RVTY REVVITY INC 20.22 11.48B

About IQV

Company Profile

IQV logo image IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 90,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Company Info

IQVIA HOLDINGS INC

2400 Ellis Road

Durham NORTH CAROLINA 27703 US

CEO: Ari Bousbib

Employees: 90000

IQV Company Website

IQV Investor Relations

Phone: 19199982000

IQVIA HOLDINGS INC / IQV FAQ

Can you describe the business of IQVIA HOLDINGS INC?

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 90,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.


What is the current price of IQV stock?

The current stock price of IQV is 220.52 USD. The price increased by 0.28% in the last trading session.


What is the dividend status of IQVIA HOLDINGS INC?

IQV does not pay a dividend.


How is the ChartMill rating for IQVIA HOLDINGS INC?

IQV has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in IQVIA HOLDINGS INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IQV.


Can you provide the number of employees for IQVIA HOLDINGS INC?

IQVIA HOLDINGS INC (IQV) currently has 90000 employees.


IQV Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to IQV. When comparing the yearly performance of all stocks, IQV turns out to be only a medium performer in the overall market: it outperformed 58.25% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IQV Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to IQV. IQV has an excellent profitability rating, but there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IQV Financial Highlights

Over the last trailing twelve months IQV reported a non-GAAP Earnings per Share(EPS) of 11.47. The EPS increased by 9.13% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.88%
ROA 4.32%
ROE 21.41%
Debt/Equity 2.45
Chartmill High Growth Momentum
EPS Q2Q%6.44%
Sales Q2Q%5.32%
EPS 1Y (TTM)9.13%
Revenue 1Y (TTM)3.6%

IQV Forecast & Estimates

29 analysts have analysed IQV and the average price target is 220.67 USD. This implies a price increase of 0.07% is expected in the next year compared to the current price of 220.52.

For the next year, analysts expect an EPS growth of 7.56% and a revenue growth 5.12% for IQV


Analysts
Analysts81.38
Price Target220.67 (0.07%)
EPS Next Y7.56%
Revenue Next Year5.12%

IQV Ownership

Ownership
Inst Owners102.98%
Ins Owners0.86%
Short Float %2.78%
Short Ratio2.99